Neuroinflammation and Alteration of the Blood-Brain Barrier in Alzheimer´s Disease

  • Soto-Rojas L
  • Cruz-López F
  • Ontiveros-Torres M
  • et al.
N/ACitations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Amyloid β peptide, which is aggregated extracellularly in the neuritic plaques, generates a constant inflammatory environment and prolonged, activation of microglial and astroglial cells that potentiate neuronal damage and have been involved in the alteration of the BBB, damaging the permeability of blood vessels. Maybe as a consequence of degradation of tight junctions proteins, favouring the loss of these junctions, altering the permeability of blood vessels. Understanding the mechanisms of action of different species of beta amyloid peptide could lead to new therapeutic interventions directed to inhibit Aβ aggregation at the level of oligomers, which are much more toxic than the fibrillary form. It is important to understand the mechanisms of action of caspase-5, in this pathological process of amyloid β peptide, emphasizing the clinical importance of casapasa-5 and its relation to the process of neuroin‐ flammation.

Cite

CITATION STYLE

APA

Soto-Rojas, L. O., Cruz-López, F. de la, Ontiveros-Torres, M. A., Viramontes-Pintos, A., Cárdenas-Aguayo, M. del C., Meraz-Ríos, M. A., … Luna-Muñoz, J. (2015). Neuroinflammation and Alteration of the Blood-Brain Barrier in Alzheimer´s Disease. In Alzheimer’s Disease - Challenges for the Future. InTech. https://doi.org/10.5772/60024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free